Scientists at Dundee University have carried out a clinical trial using metformin, a drug commonly used for typeII diabetes, on patients with heart failure.

The research suggests metformin not only enables HF patients to do more exercise, but also helps them lose weight and improve the performance of their fat hormones.

Professor Chim Lang, Professor of Cardiology at Dundee University, said he believed the research could help lead to a new treatment strategy for patients with heart failure.
The study has been published in the European Journal of Heart Failure.

Source: European Journal of Heart Failure   ;     The Herald